Related references
Note: Only part of the references are listed.Nanoparticle Delivery of Cancer Drugs
Andrew Z. Wang et al.
ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)
Drugging the PI3 Kinome: From Chemical Tools to Drugs in the Clinic
Paul Workman et al.
CANCER RESEARCH (2010)
Chemoradiotherapy in Gastrointestinal Malignancies
C. G. Willett et al.
CLINICAL ONCOLOGY (2009)
Self-assembled lipid-polymer hybrid nanoparticles: A robust drug delivery platform
Liangfang Zhang et al.
ACS NANO (2008)
Nanotechnology and cancer
James R. Heath et al.
ANNUAL REVIEW OF MEDICINE (2008)
Drug discovery approaches targeting the PI3K/Akt pathway in cancer
C. Garcia-Echeverria et al.
ONCOGENE (2008)
Nanoparticles in medicine: Therapeutic applications and developments
L. Zhang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
The phosphatidylinositol 3-kinase inhibitor, PX-866, is a potent inhibitor of cancer cell motility and growth in three-dimensional cultures
Amy L. Howes et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Covalent reactions of Wortmannin under physiological conditions
Hushan Yuan et al.
CHEMISTRY & BIOLOGY (2007)
The concurrent chemoradiation paradigm - general principles
Tanguy Y. Seiwert et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Chemoradiotherapy in the treatment of cervical cancer
Patricia J. Eifel
SEMINARS IN RADIATION ONCOLOGY (2006)
Pegylated wortmannin and 17-hydroxywortmannin conjugates as phosphoinositide 3-kinase inhibitors active in human tumor xenograft models
TM Zhu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Wortmannin-C20 conjugates generate wortmannin
HS Yuan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
PWT-458, a novel pegylated-17-hydroxywortmannin, inhibits phosphatidylinositol 3-kinase signaling and suppresses growth of solid tumors
K Yu et al.
CANCER BIOLOGY & THERAPY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
DNA-PK: the major target for wortmannin-mediated radiosensitization by the inhibition of DSB repair via NHEJ pathway
M Hashimoto et al.
JOURNAL OF RADIATION RESEARCH (2003)
Autophosphorylation of the DNA-dependent protein kinase catalytic subunit is required for rejoining of DNA double-strand breaks
DW Chan et al.
GENES & DEVELOPMENT (2002)